United States · FDA National Drug Code directory
Orapaz
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73614-417_2de0b332-58a4-0bb4-e063-6394a90a1a45
- Product NDC
- 73614-417
- Form
- KIT
- Composition / generic term
- Cephalexin, Ibuprofen, Chlorhexidine Gluconate
- Labeler
- Brisk Pharmaceuticals
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20250210
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (73614-417-03) * 30 CAPSULE in 1 BOTTLE (73614-202-03) * 30 TABLET, FILM COATED in 1 BOTTLE (73614-201-03) * 118 mL in 1 BOTTLE (73614-203-01) * 118 mL in 1 BOTTLE (73614-203-01) · 73614-417-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →